en
Resources center summary
Proton Therapy Publication
December 2022
Early Toxicity and Patient-Reported Cosmetic Outcomes in Patients Treated With Adjuvant Proton-Based Radiotherapy After Breast-Conserving Surgery.
Proton Therapy Publication
November 2022
Proton therapy for isolated local regional recurrence of breast cancer after mastectomy alone.
Proton Therapy Publication
January 2023
Renal function in abdominal neuroblastoma patients undergoing proton radiotherapy.
Proton Therapy Publication
November 2022
A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases.
Proton Therapy Publication
August 2022
Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial.
Proton Therapy Publication
September 2022
The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer
Proton Therapy Publication
September 2022
Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade.
Webinar
April 23, 2022
Breast, The Value of Protons, Cardiotoxicity and RadComp
Shannon
MacDonald
Webinar
April 23, 2022
Proton Therapy for GI Cancers
Michael
Chuong
Webinar
April 23, 2022
Proton Therapy for Prostate Cancer: Current Status & Future Directions
Andrew
Lee
Proton Therapy Publication
September 2022
Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy.
Proton Therapy Publication
September 2022
Trends in radiotherapy administration in the management of hepatocellular carcinoma
Proton Therapy Publication
June 2022
Hematologic Toxicity Comparison of Intensity Modulated Proton Therapy and Intensity Modulated Radiation Therapy in Anal Cancer Patients.
Proton Therapy Publication
June 2022
Dose-escalated proton therapy with elective nodal irradiation and concomitant chemotherapy for unresectable, borderline resectable, or medically inoperable pancreatic cancer: a phase II trial.
Proton Therapy Publication
June 2022
Proton Therapy in the Management of Pancreatic Cancer.
Proton Therapy Publication
June 2022
Dose-escalated PT with elective nodal irradiation and concomitant chemotherapy for unresectable, borderline resectable, or medically inoperable pancreatic cancer
Proton Therapy Publication
May 2022
The Role of Hypofractionation in Proton Therapy.
Proton Therapy Publication
May 2022
Secondary Malignancy Risk Following Proton vs. X-ray Radiotherapy of Thymic Epithelial Tumors: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk.
Proton Therapy Publication
April 2022
A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute.
Proton Therapy Publication
February 2022
Factors associated with LT survival in gemcitabine-concurrent PT for non-metastatic LAPC